Retrospective Analysis of Tissue Plasminogen Activator as an Adjuvant Treatment for Calciphylaxis
Author(s) -
Rokea A. elAzhary,
Allison K. Arthur,
Mark D.P. Davis,
Marian T. McEvoy,
Lawrence E. Gibson,
Amy L. Weaver,
Michael Camilleri,
David A. Wetter,
Roger H. Weenig
Publication year - 2013
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/2013.jamadermatol.5
Subject(s) - calciphylaxis , medicine , tissue plasminogen activator , retrospective cohort study , adjuvant , plasminogen activator , surgery , dermatology , calcification
To report our experience with low-dose tissue plasminogen activator in the treatment of calciphylaxis, a rare, usually fatal thrombotic condition that results in ischemia, necrosis, and infarction of adipose and cutaneous tissue.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom